Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)

NCT05827523 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

520

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Cisplatin

Sponsor

National Cancer Center, Korea